Open Access

Interrelation of inflammation and oxidative stress in liver cirrhosis

  • Authors:
    • Mihnea Marian Pomacu
    • Maria Diana Trașcă
    • Vlad Pădureanu
    • Ana Maria Bugă
    • Ana Marina Andrei
    • Elena Camelia Stănciulescu
    • Ileana Monica Baniță
    • Dumitru Rădulescu
    • Cătălina Gabriela Pisoschi
  • View Affiliations

  • Published online on: April 14, 2021     https://doi.org/10.3892/etm.2021.10034
  • Article Number: 602
  • Copyright: © Pomacu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Recently, the trend of research has been focused on the role of hematological indicators in assessing the activities of various diseases. The aim of the present study was to determine the usefulness of such hematological indicators for assessment of the relationship between inflammation and oxidative stress in order to provide new predictive tools for a non‑invasive investigation of disease outcome for liver cirrhosis patients. A total of 35 subjects with compensated or decompensated liver cirrhosis and 10 age‑matched healthy volunteers were included in this study. The patients were divided into two groups: Group 1, patients with toxic metabolic cirrhosis due to ethanol consumption; group 2, patients with liver cirrhosis following hepatitis B virus (HBV) and hepatitis C virus (HCV) infection. Using hematological data obtained after the complete counting of peripheral blood cells, the monocyte/lymphocyte (MLR), neutrophil/lymphocyte (NLR) and platelet/lymphocyte (PLR) ratios as well as systemic immune inflammation biomarkers were determined. The erythrocyte sedimentation ratio (ESR), C‑reactive protein (CRP), fibrinogen and biochemical parameters related to liver function were also registered. Thiobarbituric acid reactive substances (TBARS), protein carbonyl content (PCARB), and total antioxidant capacity (TAC) were also investigated in the peripheral blood samples of healthy subjects and liver cirrhosis patients. The results revealed that NLR, MLR and PLR were significantly increased in group 2. PLR was significantly increased in group 1 compared with that noted in the control group. TBARS and PCARB were increased in patients from group 1 compared to patients from group 2 and the control group. However, no difference in TAC was found between the liver cirrhosis groups and the control. We showed that the pro‑inflammatory status of liver cirrhosis patients can be easily appreciated by NLR, MLR but not PLR. However, the increase in these ratios was not significantly associated with a decrease in the antioxidant capacity and an augmentation of oxidative stress markers for the patients diagnosed with cirrhosis included in the two groups of study.
View Figures
View References

Related Articles

Journal Cover

June-2021
Volume 21 Issue 6

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Pomacu MM, Trașcă MD, Pădureanu V, Bugă AM, Andrei AM, Stănciulescu EC, Baniță IM, Rădulescu D and Pisoschi CG: Interrelation of inflammation and oxidative stress in liver cirrhosis. Exp Ther Med 21: 602, 2021
APA
Pomacu, M.M., Trașcă, M.D., Pădureanu, V., Bugă, A.M., Andrei, A.M., Stănciulescu, E.C. ... Pisoschi, C.G. (2021). Interrelation of inflammation and oxidative stress in liver cirrhosis. Experimental and Therapeutic Medicine, 21, 602. https://doi.org/10.3892/etm.2021.10034
MLA
Pomacu, M. M., Trașcă, M. D., Pădureanu, V., Bugă, A. M., Andrei, A. M., Stănciulescu, E. C., Baniță, I. M., Rădulescu, D., Pisoschi, C. G."Interrelation of inflammation and oxidative stress in liver cirrhosis". Experimental and Therapeutic Medicine 21.6 (2021): 602.
Chicago
Pomacu, M. M., Trașcă, M. D., Pădureanu, V., Bugă, A. M., Andrei, A. M., Stănciulescu, E. C., Baniță, I. M., Rădulescu, D., Pisoschi, C. G."Interrelation of inflammation and oxidative stress in liver cirrhosis". Experimental and Therapeutic Medicine 21, no. 6 (2021): 602. https://doi.org/10.3892/etm.2021.10034